85 related articles for article (PubMed ID: 9549359)
1. [Study of T cell-directed gene transfer for a patient with ADA deficiency].
Sakiyama Y; Ariga T; Kawamura N
Nihon Rinsho; 1998 Mar; 56(3):696-700. PubMed ID: 9549359
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
3. [The gene therapy for a patient with ADA deficiency; report of the first gene therapy trial in Japan].
Ariga T; Kawamura N; Sakiyama Y
Nihon Rinsho; 1997 Jun; 55(6):1572-9. PubMed ID: 9200950
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y; Ariga T; Ohtsu M
Nihon Rinsho; 2005 Mar; 63(3):448-52. PubMed ID: 15773344
[TBL] [Abstract][Full Text] [Related]
5. Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.
Onodera M; Ariga T; Kawamura N; Kobayashi I; Ohtsu M; Yamada M; Tame A; Furuta H; Okano M; Matsumoto S; Kotani H; McGarrity GJ; Blaese RM; Sakiyama Y
Blood; 1998 Jan; 91(1):30-6. PubMed ID: 9414266
[TBL] [Abstract][Full Text] [Related]
6. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow gene therapy for adenosine deaminase deficiency.
Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the induced T cells in a ADA-defective case 4 years after gene induction targeted at the peripheral T cells and a simulation study on gene re-induction].
Ichimura R
Hokkaido Igaku Zasshi; 2004 Nov; 79(6):647-57. PubMed ID: 15675295
[No Abstract] [Full Text] [Related]
10. Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cells.
Braakman E; Van Beusechem VW; Van Krimpen BA; Fischer A; Bolhuis RL; Valerio D
Eur J Immunol; 1992 Jan; 22(1):63-9. PubMed ID: 1730260
[TBL] [Abstract][Full Text] [Related]
11. Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.
Culver KW; Osborne WR; Miller AD; Fleisher TA; Berger M; Anderson WF; Blaese RM
Transplant Proc; 1991 Feb; 23(1 Pt 1):170-1. PubMed ID: 1846711
[No Abstract] [Full Text] [Related]
12. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
Ramsey WJ; Mullen CA; Blaese RM
Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
[TBL] [Abstract][Full Text] [Related]
13. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
14. Retroviral-mediated gene transfer into mammalian cells.
Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
Hoogerbrugge PM; van Beusechem VW; Fischer A; Debree M; le Deist F; Perignon JL; Morgan G; Gaspar B; Fairbanks LD; Skeoch CH; Moseley A; Harvey M; Levinsky RJ; Valerio D
Gene Ther; 1996 Feb; 3(2):179-83. PubMed ID: 8867866
[TBL] [Abstract][Full Text] [Related]
16. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency.
Blaese RM
Pediatr Res; 1993 Jan; 33(1 Suppl):S49-53; discussion S53-5. PubMed ID: 8433875
[TBL] [Abstract][Full Text] [Related]
17. Transfer of the adenosine deaminase (ADA) gene of a B-lymphoblastoid cell line (LCL) to an ADA-deficient LCL by a microcell-mediated chromosome transfer technique.
Sawami H; Ito K; Norioka M; Monden S; Fujita M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1033-44. PubMed ID: 2588953
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.
Blaese RM; Culver KW; Miller AD; Carter CS; Fleisher T; Clerici M; Shearer G; Chang L; Chiang Y; Tolstoshev P; Greenblatt JJ; Rosenberg SA; Klein H; Berger M; Mullen CA; Ramsey WJ; Muul L; Morgan RA; Anderson WF
Science; 1995 Oct; 270(5235):475-80. PubMed ID: 7570001
[TBL] [Abstract][Full Text] [Related]
19. A murine model for genetic manipulation of the T cell compartment.
Gu J; Kuo ML; Rivera A; Sutkowski N; Ron Y; Dougherty JP
Exp Hematol; 1996 Oct; 24(12):1432-40. PubMed ID: 8913290
[TBL] [Abstract][Full Text] [Related]
20. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions.
Ferrari G; Rossini S; Nobili N; Maggioni D; Garofalo A; Giavazzi R; Mavilio F; Bordignon C
Blood; 1992 Sep; 80(5):1120-4. PubMed ID: 1325209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
